The proinflammatory cytokine IL-18 confers protective effects against cancer proliferation, such as that of lung cancer, in several murine models [13,34], and the benefits of recombinant human IL-18 have been shown in preclinical trials for cancer treatment [35]. This evidence concerns the gene IL18 and lung carcinoma.